Blood DonorNCT02646059
The Effective Ways of Recruiting Lapsed Blood Donors: a Stratified Randomized Pilot Study
A study testing Text message and Telephone in people with Blood Donor, run by Guangzhou Blood Center at 1 site in China.
Trial summary
Blood donor recruitment is an important issue in every country, since the blood supply pressure become more and more intense. Donor retention is even more important, because it is easier to recruit an old customers than a new one. Read more about this study
- Who is it for?
- Ages 18 to 50 years
- Conditions the study is for
- Blood Donor
- What is being tested?
- Text message and Telephone
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1,188 participants
- Where
- 1 siteChina
- Study dates
- Nov 2015to Jun 2016
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 50 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Donated blood at least once between 2009 to 2013, and the blood test result is qualified.
Who cannot join
- Having donated again before intervened.
Trial locations and contacts
1 site in 1 country.
About this study
Blood donor recruitment is an important issue in every country, since the blood supply pressure become more and more intense. Donor retention is even more important, because it is easier to recruit an old customers than a new one. Therefore, figuring the most effective ways of recruiting lapsed blood donors and understanding the reasons of not donating blood again is critical and vital for the development of blood donation.
- Conditions
- Blood Donor
- Being tested
- Text message, Telephone
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Text messageOther
Text messages would be sent via the messaging platform of Guangzhou Blood Center. The feedback of sending status (received, failed to receive, or unknown) would be marked on every number. Four to six months follow-up, blood donation rate would be checked.
TelephoneOther
Status (response, no answer, line issue, wrong number or refused to be interviewed) of every donor in this groups would be marked. Four to six months follow-up, blood donation rate would be checked.
| Study group | Role | What they receive |
|---|---|---|
| Text group | Experimental | Text messages containing reminds of blood donation information would be sent to donors in this group. Receives: Other: Text message |
| Telephone group | Experimental | Investigators would give telephone calls to the donors in this group, ask the reasons why they stopped donating blood. Receives: Other: Telephone |
| Control group | No intervention | No intervention will be giving to this group. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Blood donation rate
Number of blood donors donate blood again divided by the number of participants in every group after intervened.
Measured: four to six months
Secondary outcomes (1)
Reasons of not donating again
The reasons of not donating again in the telephone group.
Measured: 1 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Jan 2016 (estimated)
- Study startNov 2015
- Primary completionMar 2016
- Study completionJun 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Blood DonorStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 1,188 participants (actual)
Sponsor and investigators
- Lead sponsor
- Guangzhou Blood Center
- Sponsor type
- Other government
- Responsible party
- Principal investigator, OUYANG Jian, Guangzhou Blood Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02646059
- Sponsor's protocol ID
- GuangzhouBC1
- Status last verified
- Jul 2017
- First submitted
- 4 Jan 2016
- Last updated
- 1 Aug 2017
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Aug 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effective Ways of Recruiting Lapsed Blood Donors: a Stratified Randomized Pilot Study
- ClinicalTrials.gov ID
- NCT02646059
- Acronym / sponsor ID
- GuangzhouBC1
- Conditions
- Blood Donor
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 1,188 participants (actual)
- Lead sponsor
- Guangzhou Blood CenterOther government
- Study start
- Nov 2015
- Primary completion
- Mar 2016 (actual)
- Study completion
- Jun 2016 (actual)
- First posted
- 5 Jan 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Blood donor recruitment is an important issue in every country, since the blood supply pressure become more and more intense. Donor retention is even more important, because it is easier to recruit an old customers than a new one. Therefore, figuring the most effective ways of recruiting lapsed blood donors and understanding the reasons of not donating blood again is critical and vital for the development of blood donation.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Text group | Experimental | Other: Text messageText messages containing reminds of blood donation information would be sent to donors in this group. |
| Telephone group | Experimental | Other: TelephoneInvestigators would give telephone calls to the donors in this group, ask the reasons why they stopped donating blood. |
| Control group | No intervention | –No intervention will be giving to this group. |
Who may qualify
- Ages
- 18 to 50 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- Donated blood at least once between 2009 to 2013, and the blood test result is qualified.
Key exclusion criteria (1 listed)
- Having donated again before intervened.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Text messageText messages would be sent via the messaging platform of Guangzhou Blood Center. The feedback of sending status (received, failed to receive, or unknown) would be marked on every number. Four to six months follow-up, blood donation rate would be checked. | Other | Text group |
| TelephoneStatus (response, no answer, line issue, wrong number or refused to be interviewed) of every donor in this groups would be marked. Four to six months follow-up, blood donation rate would be checked. | Other | Telephone group |
Primary outcome
Blood donation rate
Time frame: four to six months
Number of blood donors donate blood again divided by the number of participants in every group after intervened.
1 secondary outcome
Reasons of not donating again
Time frame: 1 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Aug 2017.
Related trials for Blood Donor
Not yet recruitingObservational study
Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use
Blood Donors, Apheresis
Enrolling by invitationObservational study
Screening for Hematology Branch Protocols
Hematologic Disease and Disorders, Donors
RecruitingObservational study
COLLECT BLOOD/RESEARCH USE
Blood Donors, Research Subjects
Active, not recruitingObservational study
Blood Biomarkers in Pediatric Kidney Transplant Recipients
Rejection of Kidney Allograft
RecruitingObservational study
Trifecta-Lung cfDNA-MMDx Study
Lung Transplantation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Text message and Telephone in people with Blood Donor, run by Guangzhou Blood Center at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Blood donation rate (time frame: four to six months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Aug 2017.